Careers in Oncology
More recently Menarini has made a commitment to oncology, investing in a pipeline of five investigational compounds for the treatment of a variety of haematological and/or solid tumours, and through the acquisition of Stemline Therapeutics in June 2020, Menarini strengthened its oncology portfolio with the addition of both commercial and clinical-stage assets.
It is an exciting time in the company’s development and an excellent opportunity for individuals joining us to contribute to building and shaping Menarini Stemline’s Oncology business.